Commercially Available Home Pelvic Training Devices for the Treatment of Pelvic Floor Disorders

Pennycuff, Jon F.; Borazjani, Ali; Wang, Haijun; Iglesia, Cheryl B.

doi:10.1097/aog.0000000000004860

Cited by 9 publications

(5 citation statements)

References 49 publications

(147 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent meta-analysis showed a large positive effect of these devices on both incontinence and urogenital distress. 28 The analysis did not evaluate the effect on sexual dysfunction. 28 Vaginal laser therapy This emerging, energy-based treatment may stimulate Lactobacillus and other premenopausal flora and regenerate connective tissue in the vagina, improving vaginal health and restoring a normal vaginal pH.…”

Section: Nonpharmacologic Therapies Pelvic Floor Muscle Training and ...mentioning

confidence: 99%

“…28 The analysis did not evaluate the effect on sexual dysfunction. 28 Vaginal laser therapy This emerging, energy-based treatment may stimulate Lactobacillus and other premenopausal flora and regenerate connective tissue in the vagina, improving vaginal health and restoring a normal vaginal pH. 20 However, in 2018, the FDA issued a warning asserting that these devices had not been adequately evaluated for use in vaginal rejuvenation procedures and may pose a risk for patient injury.…”

Section: Nonpharmacologic Therapies Pelvic Floor Muscle Training and ...mentioning

confidence: 99%

“…Commercially available at-home pelvic floor training devices include devices that use intravaginal resistance, biofeedback, electrostimulation, mechanical stimulation, magnets, and combination modalities. A recent meta-analysis showed a large positive effect of these devices on both incontinence and urogenital distress 28. The analysis did not evaluate the effect on sexual dysfunction 28…”

Section: Nonpharmacologic Therapiesmentioning

confidence: 99%

“…A recent meta-analysis showed a large positive effect of these devices on both incontinence and urogenital distress 28. The analysis did not evaluate the effect on sexual dysfunction 28…”

Section: Nonpharmacologic Therapiesmentioning

confidence: 99%

See 3 more Smart Citations

A practical guide to managing genitourinary syndrome of menopause in primary care

Schmidt

2023

Jaapa

View full text Add to dashboard Cite

Females spend a third to half of their life in menopause, and the number of US females in menopause is growing. A high percentage of postmenopausal females experience bothersome, sometimes debilitating genitourinary symptoms, which can affect quality of life. The genitourinary syndrome of menopause (GSM) describes the condition previously referred to as vulvovaginal atrophy, atrophic vaginitis, or urogenital atrophy. Of concern, many patients with symptoms of GSM have never been asked about nor have they initiated conversations about these concerns with a healthcare provider. This article addresses the need to improve screening, identification, and patient-centered management in primary care of females with GSM.

show abstract

Section: Nonpharmacologic Therapies Pelvic Floor Muscle Training and ...mentioning

confidence: 99%

Section: Nonpharmacologic Therapies Pelvic Floor Muscle Training and ...mentioning

confidence: 99%

Section: Nonpharmacologic Therapiesmentioning

confidence: 99%

“…A recent meta-analysis showed a large positive effect of these devices on both incontinence and urogenital distress 28. The analysis did not evaluate the effect on sexual dysfunction 28…”

Section: Nonpharmacologic Therapiesmentioning

confidence: 99%

See 2 more Smart Citations

A practical guide to managing genitourinary syndrome of menopause in primary care

Schmidt

2023

Jaapa

View full text Add to dashboard Cite

show abstract

“…There are many explanations for this failure to utilize first-line care, including a lack of confidence in PFMT that has been expressed by clinicians, skepticism regarding efficacy by patients themselves, and difficulty accessing care owing to constraints of time, cost, or provider availability [ 9 – 11 ]. Advances in technology are helping to define new pathways for the implementation of PFMT for UI, making access to effective PFMT available to more women [ 12 – 14 ]. In a previous randomized controlled trial, the superiority of a prescription motion-based device over home PFMT with written and audio instructions for the treatment of stress and mixed UI was demonstrated following an 8-week program [ 15 ].…”

Section: Introductionmentioning

confidence: 99%

A Motion-based Device Urinary Incontinence Treatment: A Longitudinal Analysis at 18 and 24 Months

Weinstein,

Dunivan,

Guaderrama

et al. 2024

Int Urogynecol J

View full text Add to dashboard Cite

Introduction and hypothesis There are sparse data regarding the long-term efficacy of pelvic floor muscle training (PFMT) for the treatment of urinary incontinence (UI). The objective of this study was to evaluate the impact of an 8-week PFMT program guided by a motion-based intravaginal device versus a standard home program over 24 months. Methods Between October 2020 and March 2021, a total of 363 women with stress or stress-predominant mixed UI were randomized and completed an 8-week PFMT program using a motion-based intravaginal device (intervention group) or a home program following written/video instructions (control group). Participants were not asked to continue training after the 8-week program. At 18 and 24 months’ follow-up, the Urogenital Distress Inventory, short-form (UDI-6) and Patient Global Impression of Improvement (PGI-I) were collected. In the original trial, a total of 139 participants in each arm were needed to detect a 0.3 effect size (alpha = 0.05, power 0.8, one-tailed t test) in the difference in UDI-6 scores. Results A total of 231 participants returned 24-month data. Mean age at 24 months was 51.7 ± 14.5 years, and mean BMI was 31.8 ± 7.4 kg/m2. Mean change in UDI-6 scores from baseline to 24 months was greater in the intervention group than the control group (−21.1 ± 24.5 vs −14.8 ± 19.4, p = 0.04). Reported improvement using PGI-I was greater in the intervention group than in the control group at 24 months (35% vs 22%, p = 0.03, OR 1.95(95% CI 1.08, 3.57). Conclusions Pelvic floor muscle training guided by a motion-based prescription intravaginal device yielded durable and significantly greater UI symptom improvement than a standard home program, even in the absence of continued therapy.

show abstract

APhA OTC - Home Medical Equipment

Krinsky

2024

View full text Add to dashboard Cite

Commercially Available Home Pelvic Training Devices for the Treatment of Pelvic Floor Disorders

Abstract: To assess the clinical efficacy of commercially available pelvic muscle training devices on the treatment of pelvic floor disorders.

Cited by 9 publications

References 49 publications

A practical guide to managing genitourinary syndrome of menopause in primary care

A practical guide to managing genitourinary syndrome of menopause in primary care

A Motion-based Device Urinary Incontinence Treatment: A Longitudinal Analysis at 18 and 24 Months

APhA OTC - Home Medical Equipment

Contact Info

Product

Resources

About